Unique substrate specificity of anaplastic lymphoma kinase (ALK): Development of phosphoacceptor peptides for the assay of ALK activity

被引:49
作者
Donella-Deana, A
Marin, O
Cesaro, L
Gunby, RH
Ferrarese, A
Coluccia, AML
Tartari, CJ
Mologni, L
Scapozza, L
Gambacorti-Passerini, C
Pinna, LA
机构
[1] Univ Padua, Dept Biochem, I-35121 Padua, Italy
[2] Venetian Inst Mol Med, I-35129 Padua, Italy
[3] Natl Canc Inst, Dept Expt Oncol, I-20133 Milan, Italy
[4] Univ Geneva, Pharm Sect, Chim Therapeut Lab, CH-1211 Geneva, Switzerland
关键词
D O I
10.1021/bi0472954
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The anaplastic lymphoma kinase (ALK), whose constitutively active fusion proteins are responsible for 5- 10% of non-Hodgkin's lymphomas, shares with the other members of the insulin receptor kinase (IRK) subfamily an activation loop (A-loop) with the triple tyrosine motif Y-x-x-x-Y-Y. However, the amino acid sequence of the ALK A-loop differs significantly from the sequences of both the IRK A-loop and the consensus A-loop for this kinase subfamily. A major difference is the presence of a unique "RAS" triplet between the first and second tyrosines of the ALK A-loop, which in IRK is replaced by "ETD". Here we show that a peptide reproducing the A-loop of ALK is readily phosphorylated by ALK, while a homologous IRK A-loop peptide is not unless its "ETD" triplet is substituted by "RAS". Phosphorylation occurs almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif, as judged by Edman analysis of the phosphoradiolabeled product. Consequently, a peptide in which the first tyrosine had been replaced by phenylalanine (FYY) was almost unaffected by ALK. In contrast, a peptide in which the second and third tyrosines had been replaced by phenylalanine (YFF) was phosphorylated more rapidly than the parent peptide (YYY). A number of substitutions in the YFF peptide outlined the importance of Ile and Arg at positions n - I and n + 6 in addition to the central triplet, to ensure efficient phosphorylation by ALK. Such a peculiar substrate specificity allows the specific monitoring of ALK activity in crude extracts of NPM-ALK positive cells, using the YFF peptide, which is only marginally phosphorylated by a number of other tyrosine kinases.
引用
收藏
页码:8533 / 8542
页数:10
相关论文
共 43 条
  • [1] Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity
    Bai, RY
    Dieter, P
    Peschel, C
    Morris, SW
    Duyster, J
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 6951 - 6961
  • [2] Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway
    Bai, RY
    Tao, OY
    Miething, C
    Morris, SW
    Peschel, C
    Duyster, J
    [J]. BLOOD, 2000, 96 (13) : 4319 - 4327
  • [3] Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
    Bischof, D
    Pulford, K
    Mason, DY
    Morris, SW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) : 2312 - 2325
  • [4] Oncogenic kinase signalling
    Blume-Jensen, P
    Hunter, T
    [J]. NATURE, 2001, 411 (6835) : 355 - 365
  • [5] The spleen protein-tyrosine kinase TPK-IIB is highly similar to the catalytic domain of p72(syk)
    Brunati, AM
    James, P
    Guerra, B
    Ruzzene, M
    DonellaDeana, A
    Pinna, LA
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 240 (02): : 400 - 407
  • [6] ISOLATION AND IDENTIFICATION OF 2 PROTOONCOGENE PRODUCTS RELATED TO C-FGR AND FYN IN A TYROSINE-PROTEIN-KINASE FRACTION OF RAT SPLEEN
    BRUNATI, AM
    JAMES, P
    DONELLADEANA, A
    MATOSKOVA, B
    ROBBINS, KC
    PINNA, LA
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 216 (01): : 323 - 327
  • [7] NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
    Chiarle, R
    Gong, JZ
    Guasparri, I
    Pesci, A
    Cai, J
    Liu, J
    Simmons, WJ
    Dhall, G
    Howes, J
    Piva, R
    Inghirami, G
    [J]. BLOOD, 2003, 101 (05) : 1919 - 1927
  • [8] ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor
    Coffin, CM
    Patel, A
    Perkins, S
    Elenitoba-Johnson, KSJ
    Perlman, E
    Griffin, CA
    [J]. MODERN PATHOLOGY, 2001, 14 (06) : 569 - 576
  • [9] Protein kinases - the major drug targets of the twenty-first century?
    Cohen, P
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) : 309 - 315
  • [10] Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor - A comparative immunohistochemical study
    Cook, JR
    Dehner, LP
    Collins, MH
    Ma, ZG
    Morris, SW
    Coffin, CM
    Hill, DA
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) : 1364 - 1371